載入...
Evidence on the cost of breast cancer drugs is required for rational decision making
BACKGROUND: For rational decision making, assessing the cost-effectiveness and budget impact of new drugs and comparing the costs of drugs already on the market is required. In addition to value frameworks, such as the American Society of Clinical Oncology Value Framework and the European Society of...
Na minha lista:
| 發表在: | Ecancermedicalscience |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cancer Intelligence
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5931813/ https://ncbi.nlm.nih.gov/pubmed/29743945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.825 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|